Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

The American Journal of Medicine

Volumn 98, Issue 1, 1995, Pages 32-41

  Neuwelt, C Michael ^a,b   Lacks, Susan ^a,c   Kaye, Brian R ^a,b   Ellman, Jonathan B ^a,d   Borenstein, David G ^a,c  

^a HIGHLAND HOSPITAL   (United States)

^b STANFORD UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d Alta Bates Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORGANIC BRAIN SYNDROME; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; STROKE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING;

ADULT; CENTRAL NERVOUS SYSTEM DISEASES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENTAL DISORDERS; MIDDLE AGE; PLASMAPHERESIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0028894372     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)80078-3     Document Type: Article

References (43)

1. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs
2. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
3. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus
4. Intravenous cyclophosphamide therapy of severe SLE
5. Reversal of aplastic anemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide
6. High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia
7. Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide
8. The use of cyclophosphamide in the treatment of CNS lupus
9. Pulse cyclophosphamide for severe neuropsychiatric lupus
10. Is aggressive therapy effective for lupus?
11. The 1982 revised criteria for the classification of systemic lupus erythematosus
12. Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus
13. MR imaging of systemic lupus erythematosus involving the brain
14. Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the result of a consensus meeting
15. Central nervous system systemic lupus erythematosus mimicking progressive multifocal leukoencephalopathy
16. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease
17. Neuropsychiatric lupus: a case for guarded optimism
18. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus
19. Central nervous system disease in patients with systemic lupus erythematosus
20. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction
21. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus
22. Association between Lupus Psychosis and Antiribosomal P Protein Antibodies
23. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature
24. Central nervous system disease in systemic lupus erythematosus: therapy and prognosis
25. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus
26. The natural history of systemic lupus erythematosus by prospective analysis
27. Nervous system involvement in systemic lupus erythematosus
28. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus
29. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning
30. Single photon emission computerized tomography (SPECT) in neuropsychiatric SLE (NPSLE)
31. A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis
32. Plasmapheresis for lupus nephritis
33. Plasmapheresis for lupus nephritis
34. Current rheumatology comments
35. Plasmapheresis in lupus
36. Apheresis and the rheumatic diseases
37. Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee Injury
38. Plasma exchange in central nervous system involvement of systemic lupus erythematosus
39. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
40. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind placebo-controlled, crossover study
41. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of two cases
42. Infection in systemic lupus erythematosus
43. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis